In Belgium, a consortium of key academic institutions, university hospitals and innovative technology players have joined forces to build a next generation genomics platform. BlueBee is a key partner in this large scale initiative.
IMEC, recently merged with iMinds and since many years a pinnacle of early stage innovation in the micro-electronics field, Leuven and Ghent universities, together with Agilent, BlueBee, Intel and Amplidata are building a genomics infrastructure enabling the sequencing and DNA analysis of thousands of patients. The goal is to deploy a secure, affordable, efficient and scalable environment for the use of next generation sequencing in health care in Belgium. Focus domains will include IVF, non-invasive prenatal testing, cancer diagnostics and ultimately precision medicine.
BlueBee will be a key partner, providing the highly secured and scalable computational platform enable high speed and high volume analytics for the new project. This will enable researchers, clinical labs and other stakeholders to further develop advanced genomics based applications in health care for large patient cohorts.
The announcement of the collaboration got broad press coverage. See below are the two articles in Dutch in the Belgium press: